HELIOS-A: 18-month exploratory cardiac results from the phase 3 study of vutrisiran in patients with hereditary transthyretin-mediated amyloidosis

Autor: P. Garcia Pavia, J.D. Gillmore, P. Kale, J.L. Berk, M.S. Maurer, I. Conceição, M. Dicarli, S. Solomon, C. Chen, S. Arum, J. Vest, M. Grogan, C. Hababou
Rok vydání: 2023
Předmět:
Zdroj: Archives of Cardiovascular Diseases Supplements. 15:31-32
ISSN: 1878-6480
DOI: 10.1016/j.acvdsp.2022.10.056
Databáze: OpenAIRE